Eli Lilly and Company, along with a consortium of other pharmaceutical firms, has formally expressed its support for the U.S. Securities and Exchange Commission’s (SEC) proposed rule change that would…
AstraZeneca PLC (AZN), a global biopharmaceutical giant, has solidified a significant strategic partnership with CSPC Pharmaceutical Group Limited (CSPCY), one of China’s leading pharmaceutical companies, for the development and commercialization…
The pharmaceutical and life sciences sector is confronting an increasingly intricate landscape of regulatory scrutiny, expanding environmental, social, and governance (ESG) obligations, and intensifying geopolitical pressures that are reshaping global…
